Search Results - "Zaemes, Jacob P"

NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer by Szymura, Szymon J, Zaemes, Jacob P, Allison, David F, Clift, Sheena H, D'Innocenzi, Jaclyn M, Gray, Lisa G, McKenna, Brian D, Morris, Benjamin B, Bekiranov, Stefan, LeGallo, Robin D, Jones, David R, Mayo, Marty W

“…Epithelial-to-mesenchymal transition (EMT) results in changes that promote de-differentiation, migration, and invasion in non-small cell lung cancer (NSCLC)…”
Get full text

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study by Lev‐Ari, Shaked, Serzan, Michael, Wu, Tianmin, Ip, Andrew, Pascual, Lauren, Sinclaire, Brittany, Adams, Shari, Marafelias, Michael, Ayyagari, Lakshmi, Gill, Sarvarinder K., Ma, Barbara, Zaemes, Jacob P., Della Pia, Alexandra, Alaoui, Adil, Madhavan, Subha, Belouali, Anas, Pecora, Andrew, Ahn, Jaeil, Atkins, Michael B., Shah, Neil J.

“…Background Immune‐related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) are often managed via immunosuppressive agents (ISAs);…”
Get full text

Immune checkpoint inhibitors (ICI) in advanced sarcomatoid renal cell carcinoma (sRCC): A multicenter study by Gopalakrishnan, Dharmesh, Collier, Katharine, Park, Joseph J, Zaemes, Jacob P, Lam, Elaine Tat, Alaklabi, Sabah, Jaeger, Ellen, Parikh, Rahul Atul, Barata, Pedro C., Kauffman, Eric, Atkins, Michael B., Alva, Ajjai Shivaram, Yang, Yuanquan, George, Saby

“…Abstract only 4568 Background: Advanced sRCC is an aggressive disease with limited responsiveness to chemotherapy and VEGF-targeted therapies. Subgroup…”
Get full text